Zhu et al. demonstrated that it inhibits neuronal ferroptosis via modulating the lipid-metabolism gene Prostaglandin-Endoperoxide Synthase 2 (PTGS2), hence mitigating chemotherapy-associated cognitive impairment [114]. This evidence concerns the gene PTGS2 and Cognitive impairment.